Stocks TelegraphStocks Telegraph
Stock Ideas

BIO Company Profile and Key Details

NYSE : BIO

Bio-Rad Laboratories

$279.99
1.63+0.59%
At Close 4:00 PM
52.07
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Bio-Rad Laboratories, Inc. (BIO) stock surged +0.59%, trading at $279.99 on NYSE, up from the previous close of $278.36. The stock opened at $275.31, fluctuating between $274.08 and $284.45 in the recent session.

Stock Snapshot

278.36
Prev. Close
7.56B
Market Cap
274.08
Day Low
10.05
P/E Ratio
27.86
EPS (TTM)
7.58
Cash Flow per Share
275.31
Open
26.99M
Number of Shares
284.45
Day High
84.05%
Free Float in %
303.6
Book Value
194.19K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 02, 2026275.31284.17274.08279.99194.19K
Apr 01, 2026280.38282.89277.86278.36176.71K
Mar 31, 2026273.70280.60270.85278.75191.71K
Mar 30, 2026268.76272.74265.64270.36210.68K
Mar 27, 2026276.51276.51264.23265.40333.42K
Mar 25, 2026273.92276.14269.10273.60252.44K
Mar 24, 2026261.29273.79260.58272.12539.38K
Mar 23, 2026268.70270.56263.65265.00360.93K
Mar 20, 2026267.43267.73262.05264.49459.17K
Mar 19, 2026266.24270.67263.24265.00271.15K
Mar 18, 2026266.27270.90266.27267.99284.08K
Mar 17, 2026264.41272.40264.32269.48216.31K
Mar 16, 2026265.57267.82258.95261.24207.36K
Mar 13, 2026265.20270.00261.38262.80161.77K
Mar 12, 2026267.03270.05259.56261.82361.09K
Mar 11, 2026266.42270.77265.57269.89204.01K
Mar 10, 2026271.25271.32265.36267.85198.79K
Mar 09, 2026268.20272.04264.92271.44314.27K
Mar 06, 2026275.96275.96267.55269.85275.8K
Mar 03, 2026274.16281.57273.68280.19269.51K

Contact Details

Hercules, CA 94547

United States

https://www.bio-rad.com510 724 7000

About Company

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Company Information

Employees7700
Beta1.16
Sales or Revenue$2.67B
5Y Sales Change%0.191%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Frequently Asked Questions

What is the current Bio-Rad Laboratories, Inc. (BIO) stock price?
Bio-Rad Laboratories, Inc. (NYSE: BIO) stock price is $279.99 in the last trading session. During the trading session, BIO stock reached the peak price of $284.45 while $274.08 was the lowest point it dropped to. The percentage change in BIO stock occurred in the recent session was 0.59% while the dollar amount for the price change in BIO stock was $1.63.
BIO's industry and sector of operation?
The NYSE listed BIO is part of Medical - Devices industry that operates in the broader Healthcare sector. Bio-Rad Laboratories, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of BIO?
Mr. Yong Chung
Vice President of Investor Relations
Dr. Andrew J. Last Ph.D.
Executive Vice President & Chief Operating Officer
Dr. Simon May
Executive Vice President & Pres of the Life Science Group
Mr. Norman D. Schwartz
Chairman, Chief Executive Officer & Pres
Mr. Michael Crowley
Executive Vice President of Global Commercial Operations
Mr. Ilan Daskal
Executive Vice President & Chief Financial Officer
Mr. Ajit Ramalingam
Senior Vice President & Chief Accounting Officer
Lee Boyd
Senior Vice President of Global Commercial Operations - Asia Pacific
Colleen Corey
Executive Vice President of Global HR
Mr. Timothy S. Ernst
Executive Vice President, Gen. Counsel & Sec.
Ms. Dara Grantham Wright
Executive Vice President & Pres of Clinical Diagnostics Group
Matthew Werner
Senior Vice President and Chief Compliance & Privacy Officer
How BIO did perform over past 52-week?
BIO's closing price is 32.43% higher than its 52-week low of $211.43 where as its distance from 52-week high of $343.12 is -18.4%.
How many employees does BIO have?
Number of BIO employees currently stands at 7,700.
Link for BIO official website?
Official Website of BIO is: https://www.bio-rad.com
How do I contact BIO?
BIO could be contacted at phone 510 724 7000 and can also be accessed through its website. BIO operates from 1000 Alfred Nobel Drive, Hercules, CA 94547, United States.
How many shares of BIO are traded daily?
BIO stock volume for the day was 194.19K shares. The average number of BIO shares traded daily for last 3 months was 290.95K.
What is the market cap of BIO currently?
The market value of BIO currently stands at $7.56B with its latest stock price at $279.99 and 26.99M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph